Showing results (2111-2120 of 2,317) with videos related to
Sort By:
Pageof 232
Bioorganic Chemistry|March 1, 2021
Design and synthesis of 4-anilinoquinazolines as Raf kinase inhibitors. Part 1. Selective B-Raf/B-RafV600E and potent EGFR/VEGFR2 inhibitory 4-(3-hydroxyanilino)-6-(1H-1,2,3-triazol-4-yl)quinazolinesCheng-I Lee, Chu-Bin Liao, Chih-Shang Chen, et al.Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Synthesis and evaluation of [18F]Fluorobutyl ethacrynic amide: a potential PET tracer for studying glutathione transferaseHo-Lien Huang, Chun-Nan Yeh, Kang-Wei Chang, et al.Cancer Communications (London, England)|May 26, 2019
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trialYuankai Shi, Jin Li, Jianming Xu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled TrialCaicun Zhou, Dingzhi Huang, Yun Fan, et al.Genes & Development|June 15, 2017
CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignanciesKaosheng Lv, Jing Jiang, Ryan Donaghy, et al.Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|May 8, 2008
Functional polymorphism of CYP2E1 gene and alcohol use disorders in a Tibetan populationWan-jun Guo, Gong-ga-lan-zi, Ou-zhu-luo-bu, et al.Translational Lung Cancer Research|June 13, 2022
The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 studyYizhuo Zhao, Qiming Wang, Li Zhang, et al.Nature Medicine|August 19, 2025
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trialShaodong Hong, Qiming Wang, Ying Cheng, et al.Plos One|June 21, 2013
Cortical surface area correlates with STON2 gene Ser307Pro polymorphism in first-episode treatment-naïve patients with schizophreniaBo Xiang, Jun-Yao Wu, Qiang Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Stephen V Liu, Martin Reck, Aaron S Mansfield, et al.Pageof 232